Kenet G - Search Results

1

Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery.

Leibovitch L, Kenet G, Mazor K, Matok I, Vardi A, Barzilay Z, Paret G. Leibovitch L, et al. Among authors: kenet g. Pediatr Crit Care Med. 2003 Oct;4(4):444-6. doi: 10.1097/01.PCC.0000074276.20537.0A. Pediatr Crit Care Med. 2003. PMID: 14525639

2

Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E. Martinowitz U, et al. Among authors: kenet g. Can J Anaesth. 2002 Dec;49(10):S15-20. Can J Anaesth. 2002. PMID: 12546003

3

High-dose recombinant factor VIIa therapy in hemophilia patients with inhibitors.

Kenet G. Kenet G. Semin Hematol. 2006 Jan;43(1 Suppl 1):S108-10. doi: 10.1053/j.seminhematol.2005.11.006. Semin Hematol. 2006. PMID: 16427376

4

Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors.

Kenet G, Martinowitz U. Kenet G, et al. Semin Hematol. 2008 Apr;45(2 Suppl 1):S38-41. doi: 10.1053/j.seminhematol.2008.03.011. Semin Hematol. 2008. PMID: 18544424 Review.

5

Hemostasis and thrombosis in critically ill children.

Kenet G, Strauss T, Kaplinsky C, Paret G. Kenet G, et al. Semin Thromb Hemost. 2008 Jul;34(5):451-8. doi: 10.1055/s-0028-1092875. Epub 2008 Oct 27. Semin Thromb Hemost. 2008. PMID: 18956285 Review.

6

Activated protein C concentrate treatment for skin necrosis under warfarin treatment in severe genetic protein C deficiency combined with prothrombin mutation and factor V Leiden.

Rosenzweig N, Strauss T, Rubinstein M, Paret G, Kenet G. Rosenzweig N, et al. Among authors: kenet g. Thromb Haemost. 2009 Feb;101(2):405-7. Thromb Haemost. 2009. PMID: 19190829 No abstract available.

7

Rescue recombinant activated factor VII for neonatal subgaleal hemorrhage.

Strauss T, Kenet G, Schushan-Eisen I, Mazkereth R, Kuint J. Strauss T, et al. Among authors: kenet g. Isr Med Assoc J. 2009 Oct;11(10):639-40. Isr Med Assoc J. 2009. PMID: 20077956 Free article. No abstract available.

8

A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor.

Livnat T, Martinowitz U, Zivelin A, Rima D, Kenet G. Livnat T, et al. Among authors: kenet g. Thromb Haemost. 2011 Apr;105(4):688-95. doi: 10.1160/TH10-08-0542. Epub 2011 Jan 12. Thromb Haemost. 2011. PMID: 21225093

9

Point of care testing in children undergoing cardiopulmonary bypass.

Tirosh-Wagner T, Strauss T, Rubinshtein M, Tamarin I, Mishaly D, Paret G, Kenet G. Tirosh-Wagner T, et al. Among authors: kenet g. Pediatr Blood Cancer. 2011 May;56(5):794-8. doi: 10.1002/pbc.22803. Epub 2010 Dec 15. Pediatr Blood Cancer. 2011. PMID: 21370413

10

Skin Necrosis and Purpura Fulminans in Children With and Without Thrombophilia--A Tertiary Center's Experience.

Fruchtman Y, Strauss T, Rubinstein M, Ben Harush M, Revel-Vilk S, Kapelushmik J, Paret G, Kenet G. Fruchtman Y, et al. Among authors: kenet g. Pediatr Hematol Oncol. 2015;32(7):505-10. doi: 10.3109/08880018.2015.1068896. Epub 2015 Oct 5. Pediatr Hematol Oncol. 2015. PMID: 26436558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters